Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 20:37 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000005 · wk-form4_1779395833.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,945 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 17,100 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,100 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 4,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,872 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,693 | $125.85 | $338,914.05 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,833 F3 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 4,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 9,452 | $125.85 | $1,189,534.20 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,654 F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:30 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 17,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 107,635 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,635 shares Expires 2026-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 59,500 | $132.00 | $7,854,000.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,006 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 107,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,566 Underlying: Common Stock · 5,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,871 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 22:53 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 63,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000009 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 152,339 F1 · balance_after: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 22:53 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 63,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000009 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,508 F1 · kind: This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 23:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | PurchaseCommon Stock | 19,551 | $112.92 | $2,207,761.48 |
DisclosureSEC source: 0001410442-25-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,149 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.48 to $113.435, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 23:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | PurchaseCommon Stock | 2,378 | $112.12 | $266,613.04 |
DisclosureSEC source: 0001410442-25-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,598 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.75 to $112.435 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:55 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 10,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031066 · wk-form4_1749761728.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,615 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:14 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 4,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000004 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,872 Underlying: Common Stock · 4,872 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:14 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,688 | $143.45 | $385,593.60 |
DisclosureSEC source: 0001410442-25-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,220 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:14 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 4,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,218 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000002 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,218 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,818 Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 23:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 15,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-25-000003 · edgardoc.xml · derivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,848 Underlying: Common Stock · 15,848 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 22:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,373 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001410442-25-000001 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,373 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 22:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,373 | $155.48 | $213,474.04 |
DisclosureSEC source: 0001410442-25-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 22:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,373 | $88.76 | $121,867.48 |
DisclosureSEC source: 0001410442-25-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 02:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001410442-24-000008 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,373 Underlying: Common Stock · 12,000 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 02:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 78 | $163.96 | $12,788.88 |
DisclosureSEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 02:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 8,250 | $163.18 | $1,346,222.63 |
DisclosureSEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,671 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $162.79 to $163.68, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 02:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,672 | $162.29 | $595,923.00 |
DisclosureSEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,921 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $161.714 to $162.710, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 02:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $88.76 | $1,065,120.00 |
DisclosureSEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,373 Underlying: Common Stock · 12,000 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,239 | $173.60 | $215,086.68 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.44 to $173.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,386 | $172.76 | $412,212.04 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,832 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.275 to $173.175, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,147 | $171.91 | $712,904.96 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,218 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.25 to $172.23, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,228 | $170.75 | $721,932.69 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,365 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.28 to $171.23, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 00:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $88.76 | $1,065,120.00 |
DisclosureSEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,373 Underlying: Common Stock · 12,000 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 788 | $180.48 | $142,219.03 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.08 to $180.54, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,375 | $179.16 | $604,658.25 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,381 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.975 to $179.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,681 | $178.49 | $657,020.95 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,756 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.96 to $178.88, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,156 | $177.50 | $737,681.69 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,437 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.92 to $177.88, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $88.76 | $1,065,120.00 |
DisclosureSEC source: 0001410442-24-000006 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,805 | $88.76 Strike: $88.76 | $337,731.80 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,373 Underlying: Common Stock · 3,805 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,440 | $88.76 Strike: $88.76 | $394,094.40 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,178 Underlying: Common Stock · 4,440 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,755 | $88.76 Strike: $88.76 | $333,293.80 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,618 Underlying: Common Stock · 3,755 shares Expires 2025-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,805 | $164.07 | $624,298.15 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,593 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to $164.5, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 22:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,805 | $88.76 | $337,731.80 |
DisclosureSEC source: 0001410442-24-000005 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.